Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q4 2023 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2024-02-01

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 1, 2024

Total Value: $296M (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 53.6%

Value $159M Shares 19,963,157 Est. Cost $20.88 Unrealized —

— MERUS N V 14.9%

Value $44M Shares 1,600,000 Est. Cost $14.08 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 11.6%

Value $34.34M Shares 3,760,869 Est. Cost $18.86 Unrealized -54.3%

NAMS NEWAMSTERDAM PHARMA COMPANY 10.8%

Value $32.05M Shares 2,869,565 Est. Cost $10.96 Unrealized -16.4%

AURA AURA BIOSCIENCES INC 9.1%

Value $26.93M Shares 3,039,892 Est. Cost $17.87 Unrealized -52.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$159M	53.6%	$20.88	—	SPONSORED ADS	152309100
—	MERUS N V	1,600,000	$44M	14.9%	$14.08	—	COM	N5749R100
PHAT	PHATHOM PHARMACEUTICALS INC	3,760,869	$34.34M	11.6%	$18.86	-54.3%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$32.05M	10.8%	$10.96	-16.4%	ORDINARY SHARES	N62509109
AURA	AURA BIOSCIENCES INC	3,039,892	$26.93M	9.1%	$17.87	-52.6%	COM	05153U107